Assessment of a cancer screening program
Several Asian countries are implementing nationwide cancer screening programs. Assessment of the effectiveness of these programs is critical to their success as this is the only way to ensure that the benefits of screening outweigh the harms. In this paper we focus on colorectal cancer (CRC) screeni...
| Main Authors: | Rabeneck, L., Lansdorp_Vogelaar, Iris |
|---|---|
| Format: | Journal Article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/50829 |
Similar Items
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)
by: Kuipers, E., et al.
Published: (2017)
The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)
by: Wieten, E., et al.
Published: (2016)
Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)
by: Haug, U., et al.
Published: (2015)
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)
by: Goede, S., et al.
Published: (2017)
Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)
by: Brenner, H., et al.
Published: (2011)
Cost effectiveness of surveillance for GI cancers
by: Omidvari, A., et al.
Published: (2016)
by: Omidvari, A., et al.
Published: (2016)
Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality
by: Etzioni, R., et al.
Published: (2013)
by: Etzioni, R., et al.
Published: (2013)
Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)
by: Haug, U., et al.
Published: (2016)
State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
Optimising the expansion of the National Bowel Cancer Screening Program
by: Cenin, D., et al.
Published: (2014)
by: Cenin, D., et al.
Published: (2014)
Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)
by: Tinmouth, J., et al.
Published: (2015)
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)
by: Van Der Vlugt, M., et al.
Published: (2017)
Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)
by: Stock, C., et al.
Published: (2011)
State disparities in colorectal cancer mortality patterns in the United States
by: Naishadham, D., et al.
Published: (2011)
by: Naishadham, D., et al.
Published: (2011)
Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)
by: Rutter, C., et al.
Published: (2015)
The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)
by: Kroep, S., et al.
Published: (2015)
Optimising the expansion of the national bowel cancer screening program - influencing the national policy agenda
by: Cenin, Dayna, et al.
Published: (2014)
by: Cenin, Dayna, et al.
Published: (2014)
Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)
by: Van Ballegooijen, M., et al.
Published: (2011)
The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
Integrating personalised genomics into risk stratification models of population screening for colorectal cancer
by: Cenin, Dayna, et al.
Published: (2017)
by: Cenin, Dayna, et al.
Published: (2017)
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)
by: Gini, A., et al.
Published: (2018)
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)
by: Meester, R., et al.
Published: (2016)
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)
by: Goede, S., et al.
Published: (2013)
Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US preventive services Task Force
by: Knudsen, A., et al.
Published: (2016)
by: Knudsen, A., et al.
Published: (2016)
European Code against Cancer, 4th Edition: Cancer screening
by: Armaroli, P., et al.
Published: (2015)
by: Armaroli, P., et al.
Published: (2015)
Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
by: Cenin, Dayna, et al.
Published: (2018)
by: Cenin, Dayna, et al.
Published: (2018)
Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)
by: Van Der Meulen, M., et al.
Published: (2016)
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Similar Items
-
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013) -
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012) -
Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011) -
Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017) -
The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)